A novel aquaporin-4-associated optic neuritis rat model with severe pathological and functional manifestations

Abstract Background Optic neuritis (ON) is a common manifestation of aquaporin-4 (AQP4) antibody seropositive neuromyelitis optica (NMO). The extent of tissue damage is frequently severe, often leading to loss of visual function, and there is no curative treatment for this condition. To develop a no...

Full description

Bibliographic Details
Main Authors: Yuko Morita, Takahide Itokazu, Toru Nakanishi, Shin-ichiro Hiraga, Toshihide Yamashita
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:https://doi.org/10.1186/s12974-022-02623-7
_version_ 1811197961579790336
author Yuko Morita
Takahide Itokazu
Toru Nakanishi
Shin-ichiro Hiraga
Toshihide Yamashita
author_facet Yuko Morita
Takahide Itokazu
Toru Nakanishi
Shin-ichiro Hiraga
Toshihide Yamashita
author_sort Yuko Morita
collection DOAJ
description Abstract Background Optic neuritis (ON) is a common manifestation of aquaporin-4 (AQP4) antibody seropositive neuromyelitis optica (NMO). The extent of tissue damage is frequently severe, often leading to loss of visual function, and there is no curative treatment for this condition. To develop a novel therapeutic strategy, elucidating the underlying pathological mechanism using a clinically relevant experimental ON model is necessary. However, previous ON animal models have only resulted in mild lesions with limited functional impairment. In the present study, we attempted to establish a feasible ON model with severe pathological and functional manifestations using a high-affinity anti-AQP4 antibody. Subsequently, we aimed to address whether our model is suitable for potential drug evaluation by testing the effect of minocycline, a well-known microglia/macrophage inhibitor. Methods AQP4-immunoglobulin G (IgG)-related ON in rats was induced by direct injection of a high-affinity anti-AQP4 monoclonal antibody, E5415A. Thereafter, the pathological and functional characterizations were performed, and the therapeutic potential of minocycline was investigated. Results We established an experimental ON model that reproduces the histological characteristics of ON in seropositive NMO, such as loss of AQP4/glial fibrillary acidic protein immunoreactivity, immune cell infiltration, and extensive axonal damage. We also observed that our rat model exhibited severe visual dysfunction. The histological analysis showed prominent accumulation of macrophages/activated microglia in the lesion site in the acute phase. Thus, we investigated the possible effect of the pharmacological inhibition of macrophages/microglia activation by minocycline and revealed that it effectively ameliorated axonal damage and functional outcome. Conclusions We established an AQP4-IgG-induced ON rat model with severe functional impairments that reproduce the histological characteristics of patients with NMO. Using this model, we revealed that minocycline treatment ameliorates functional and pathological outcomes, highlighting the usefulness of our model for evaluating potential therapeutic drugs for ON in NMO.
first_indexed 2024-04-12T01:23:17Z
format Article
id doaj.art-79d94aad56e045b99bf659e92f817a42
institution Directory Open Access Journal
issn 1742-2094
language English
last_indexed 2024-04-12T01:23:17Z
publishDate 2022-10-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj.art-79d94aad56e045b99bf659e92f817a422022-12-22T03:53:44ZengBMCJournal of Neuroinflammation1742-20942022-10-0119111210.1186/s12974-022-02623-7A novel aquaporin-4-associated optic neuritis rat model with severe pathological and functional manifestationsYuko Morita0Takahide Itokazu1Toru Nakanishi2Shin-ichiro Hiraga3Toshihide Yamashita4Department of Molecular Neuroscience, Graduate School of Medicine, Osaka UniversityDepartment of Molecular Neuroscience, Graduate School of Medicine, Osaka UniversityDepartment of Molecular Neuroscience, Graduate School of Medicine, Osaka UniversityDepartment of Molecular Neuroscience, Graduate School of Medicine, Osaka UniversityDepartment of Molecular Neuroscience, Graduate School of Medicine, Osaka UniversityAbstract Background Optic neuritis (ON) is a common manifestation of aquaporin-4 (AQP4) antibody seropositive neuromyelitis optica (NMO). The extent of tissue damage is frequently severe, often leading to loss of visual function, and there is no curative treatment for this condition. To develop a novel therapeutic strategy, elucidating the underlying pathological mechanism using a clinically relevant experimental ON model is necessary. However, previous ON animal models have only resulted in mild lesions with limited functional impairment. In the present study, we attempted to establish a feasible ON model with severe pathological and functional manifestations using a high-affinity anti-AQP4 antibody. Subsequently, we aimed to address whether our model is suitable for potential drug evaluation by testing the effect of minocycline, a well-known microglia/macrophage inhibitor. Methods AQP4-immunoglobulin G (IgG)-related ON in rats was induced by direct injection of a high-affinity anti-AQP4 monoclonal antibody, E5415A. Thereafter, the pathological and functional characterizations were performed, and the therapeutic potential of minocycline was investigated. Results We established an experimental ON model that reproduces the histological characteristics of ON in seropositive NMO, such as loss of AQP4/glial fibrillary acidic protein immunoreactivity, immune cell infiltration, and extensive axonal damage. We also observed that our rat model exhibited severe visual dysfunction. The histological analysis showed prominent accumulation of macrophages/activated microglia in the lesion site in the acute phase. Thus, we investigated the possible effect of the pharmacological inhibition of macrophages/microglia activation by minocycline and revealed that it effectively ameliorated axonal damage and functional outcome. Conclusions We established an AQP4-IgG-induced ON rat model with severe functional impairments that reproduce the histological characteristics of patients with NMO. Using this model, we revealed that minocycline treatment ameliorates functional and pathological outcomes, highlighting the usefulness of our model for evaluating potential therapeutic drugs for ON in NMO.https://doi.org/10.1186/s12974-022-02623-7Neuromyelitis opticaAxonal degenerationNeuroinflammationMacrophages/microglia activationMinocyclineOptic neuritis
spellingShingle Yuko Morita
Takahide Itokazu
Toru Nakanishi
Shin-ichiro Hiraga
Toshihide Yamashita
A novel aquaporin-4-associated optic neuritis rat model with severe pathological and functional manifestations
Journal of Neuroinflammation
Neuromyelitis optica
Axonal degeneration
Neuroinflammation
Macrophages/microglia activation
Minocycline
Optic neuritis
title A novel aquaporin-4-associated optic neuritis rat model with severe pathological and functional manifestations
title_full A novel aquaporin-4-associated optic neuritis rat model with severe pathological and functional manifestations
title_fullStr A novel aquaporin-4-associated optic neuritis rat model with severe pathological and functional manifestations
title_full_unstemmed A novel aquaporin-4-associated optic neuritis rat model with severe pathological and functional manifestations
title_short A novel aquaporin-4-associated optic neuritis rat model with severe pathological and functional manifestations
title_sort novel aquaporin 4 associated optic neuritis rat model with severe pathological and functional manifestations
topic Neuromyelitis optica
Axonal degeneration
Neuroinflammation
Macrophages/microglia activation
Minocycline
Optic neuritis
url https://doi.org/10.1186/s12974-022-02623-7
work_keys_str_mv AT yukomorita anovelaquaporin4associatedopticneuritisratmodelwithseverepathologicalandfunctionalmanifestations
AT takahideitokazu anovelaquaporin4associatedopticneuritisratmodelwithseverepathologicalandfunctionalmanifestations
AT torunakanishi anovelaquaporin4associatedopticneuritisratmodelwithseverepathologicalandfunctionalmanifestations
AT shinichirohiraga anovelaquaporin4associatedopticneuritisratmodelwithseverepathologicalandfunctionalmanifestations
AT toshihideyamashita anovelaquaporin4associatedopticneuritisratmodelwithseverepathologicalandfunctionalmanifestations
AT yukomorita novelaquaporin4associatedopticneuritisratmodelwithseverepathologicalandfunctionalmanifestations
AT takahideitokazu novelaquaporin4associatedopticneuritisratmodelwithseverepathologicalandfunctionalmanifestations
AT torunakanishi novelaquaporin4associatedopticneuritisratmodelwithseverepathologicalandfunctionalmanifestations
AT shinichirohiraga novelaquaporin4associatedopticneuritisratmodelwithseverepathologicalandfunctionalmanifestations
AT toshihideyamashita novelaquaporin4associatedopticneuritisratmodelwithseverepathologicalandfunctionalmanifestations